Encelimab (Anti-LAG3 / CD223)
Encelimab (Anti-LAG3 / CD223) (A2993-GRP)
Products
Description
Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2993 |
| Target | CD markers |